Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19398090.
- Also identified by DOI 10.1016/j.ajog.2009.02.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Herceptin (trastuzumab) is an adjuvant chemotherapy agent used in treatment of certain breast cancers. Limited information is available on the use of herceptin in pregnancy. This case is a twin pregnancy exposed to herceptin until 23 weeks' gestation. One twin had chronic renal failure develop, whereas the other twin did not.
Medical subject headings
- Antibodies, Monoclonal
- Antineoplastic Agents
- Breast Neoplasms
- Oligohydramnios
- Pregnancy Complications, Neoplastic
- Pregnancy Outcome
- Pregnancy, Multiple